We are live on ! Find out more
CVS icon

CVS Health

1,512 hedge funds and large institutions have $89.7B invested in CVS Health in 2015 Q3 according to their latest regulatory filings, with 101 funds opening new positions, 668 increasing their positions, 578 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more first-time investments, than exits

New positions opened: 101 | Existing positions closed: 61

16% more repeat investments, than reductions

Existing positions increased: 668 | Existing positions reduced: 578

2% more funds holding

Funds holding: 1,4831,512 (+29)

1.05% more ownership

Funds ownership: 82.93%83.98% (+1.1%)

2% less funds holding in top 10

Funds holding in top 10: 227223 (-4)

8% less capital invested

Capital invested by funds: $97.6B → $89.7B (-$7.88B)

13% less call options, than puts

Call options by funds: $506M | Put options by funds: $584M

Holders
1,512
Holders Change
+29
Holders Change %
+1.96%
% of All Funds
42.2%
Holding in Top 10
223
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-1.76%
% of All Funds
6.22%
New
101
Increased
668
Reduced
578
Closed
61
Calls
$506M
Puts
$584M
Net Calls
-$77.5M
Net Calls Change
-$107M
Name Holding Trade Value Shares
Change
Change in
Stake
Asset Management One
326
Asset Management One
Japan
$20.4M +$6.58M +62,626 +42%
WB
327
WesBanco Bank
West Virginia
$20.1M -$854K -8,127 -4%
SI
328
Sprott Inc
Ontario, Canada
$20M -$76.7K -730 -0.4%
HCMT
329
Highland Capital Management (Tennessee)
Tennessee
$19.8M +$709K +6,745 +3%
KFS
330
Kurt F. Somerville
$19.8M -$305K -2,900 -1%
Parallax Volatility Advisers
331
Parallax Volatility Advisers
California
$19.8M +$21.5M +204,726 +78,439%
ORI
332
Oak Ridge Investments
Illinois
$19.7M -$10.9K -104 -0.1%
HW
333
Hancock Whitney
Mississippi
$19.6M -$622K -5,913 -3%
CFB
334
Cullen/Frost Bankers
Texas
$19.5M +$1.08M +10,247 +5%
URS
335
Utah Retirement Systems
Utah
$19.5M +$116K +1,100 +0.5%
SAM
336
Shell Asset Management
Netherlands
$19.4M +$6.23M +59,252 +32%
BGCP
337
Bristol Gate Capital Partners
Ontario, Canada
$19.4M -$871K -8,286 -4%
KBC Group
338
KBC Group
Belgium
$19.4M -$9.06M -86,197 -30%
LIA
339
LS Investment Advisors
Michigan
$19.3M -$1.42M -13,536 -6%
ZIG
340
Zurich Insurance Group
Switzerland
$19.3M +$21M +200,193 New
SFM
341
Systematic Financial Management
New Jersey
$19.2M -$3.06M -29,071 -13%
BFS
342
Bradley Foster & Sargent
Connecticut
$19.2M +$5.98M +56,882 +40%
RJFSA
343
Raymond James Financial Services Advisors
Florida
$19.1M +$15.4M +146,365 +281%
FTIOP
344
Fiduciary Trust International of Pennsylvania
Pennsylvania
$19M -$8.64M -82,190 -29%
PRCM
345
Pine River Capital Management
Minnesota
$18.8M +$18.8M +179,150 +1,143%
CCM
346
Compass Capital Management
Minnesota
$18.8M -$803K -7,634 -4%
ABTD
347
Arvest Bank Trust Division
Oklahoma
$18.7M +$407K +3,868 +2%
DCM
348
Donaldson Capital Management
Indiana
$18.6M +$17.8M +169,328 +708%
UB
349
UMB Bank
Missouri
$18.6M -$396K -3,763 -2%
PGFC
350
Peapack-Gladstone Financial Corp
New Jersey
$18.6M +$569K +5,416 +3%

CVS Hedge Fund Activity: Q3 2015 in Review

1,512 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q3 2015, worth a combined $89.7B — down 8.1% from $97.6B a quarter earlier.

Buyers outnumbered sellers: 101 funds opened new CVS positions and 61 closed out — a net gain of 40 holders — while 668 added to existing stakes and 578 trimmed.

The largest buyer was Bank of America, adding an estimated $906M. The largest seller was First Pacific Advisors, cutting an estimated $414M.

  • 1,512 institutional investors held CVS Health (CVS) as of Q3 2015, up from 1,483 in Q2 2015.
  • Funds reported $89.7B of CVS Health stock for Q3 2015, down 8.1% quarter-over-quarter.
  • 101 funds opened new CVS Health positions in Q3 2015 and 61 closed out, a net change of +40 holders.
  • The largest CVS Health buyer in Q3 2015 was Bank of America, an estimated $906M added.
  • The largest CVS Health seller in Q3 2015 was First Pacific Advisors, an estimated $414M sold.

Based on aggregated 13F filings for Q3 2015.